HUP9901858A2 - Eljárás adenilszukcinát-szintetáz aktivitásának gátlására metil-tio-adenozin-foszforilázban hiányos sejtekben - Google Patents

Eljárás adenilszukcinát-szintetáz aktivitásának gátlására metil-tio-adenozin-foszforilázban hiányos sejtekben

Info

Publication number
HUP9901858A2
HUP9901858A2 HU9901858A HUP9901858A HUP9901858A2 HU P9901858 A2 HUP9901858 A2 HU P9901858A2 HU 9901858 A HU9901858 A HU 9901858A HU P9901858 A HUP9901858 A HU P9901858A HU P9901858 A2 HUP9901858 A2 HU P9901858A2
Authority
HU
Hungary
Prior art keywords
inhibiting
deficient
methylthioadenosine phosphorylase
deficient cells
treatment
Prior art date
Application number
HU9901858A
Other languages
English (en)
Inventor
Carlos J. Carrera
Dennis A. Carson
Howard B. Cottam
Tsutomu Nobori
Original Assignee
The Regents Of The University Of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Regents Of The University Of California filed Critical The Regents Of The University Of California
Publication of HUP9901858A2 publication Critical patent/HUP9901858A2/hu
Publication of HUP9901858A3 publication Critical patent/HUP9901858A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1077—Pentosyltransferases (2.4.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/25—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G01N33/567—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds utilising isolate of tissue or organ as binding agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/963—Methods of stopping an enzyme reaction or stabilizing the test materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/968—High energy substrates, e.g. fluorescent, chemiluminescent, radioactive
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Abstract

A találmány tárgyát in vivő eljárásők képezik őlyan rákbetegséekkemőterápiás kezelésére, amelyekben a tűmőrsejtek metil-tiőadenőzin-főszfőrilázban deficiensek (MTAáz-deficiensek). Közelebbről atalálmány tárgyát őlyan ráksejtek azőnősítása képezi, amelyek nemképesek MTA adeninné történő metabőlizálására, ami azadeninnűkleőtidők szintézisének mentő útvőnala. A találmány tárgyátképezi tővábbá L-alanőzin (az adenilszűkcinát-szintetáz inhibitőra)alkalmazása adenőzin-5'-mőnőfőszfát (AMP) de nővő szintézisénekgátlására ilyen ráksejtekben. A találmány szerinti megőldás alkalmasMTAáz-deficiens tűmőrők azőnősítására, és az ilyen ráktípűsőbanszenvedő páciensek kezelésére. ŕ
HU9901858A 1996-03-08 1997-01-27 Method for inhibiting adenylosuccinate synthetase activity methylthioadenosine phosphorylase deficient cells HUP9901858A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/612,542 US5840505A (en) 1993-12-29 1996-03-08 Method for inhibiting adenylosuccinate synthetase activity in methylthioadenosine phosphorylase deficient cells

Publications (2)

Publication Number Publication Date
HUP9901858A2 true HUP9901858A2 (hu) 1999-09-28
HUP9901858A3 HUP9901858A3 (en) 1999-12-28

Family

ID=24453611

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9901858A HUP9901858A3 (en) 1996-03-08 1997-01-27 Method for inhibiting adenylosuccinate synthetase activity methylthioadenosine phosphorylase deficient cells

Country Status (20)

Country Link
US (1) US5840505A (hu)
EP (1) EP0902839B1 (hu)
JP (1) JP2000509247A (hu)
KR (1) KR19990087627A (hu)
CN (1) CN1213406A (hu)
AT (1) ATE357223T1 (hu)
AU (1) AU722813B2 (hu)
BR (1) BR9708002A (hu)
CA (1) CA2244733A1 (hu)
CZ (1) CZ286698A3 (hu)
DE (1) DE69737499D1 (hu)
EA (1) EA001988B1 (hu)
HU (1) HUP9901858A3 (hu)
IL (1) IL126114A0 (hu)
NO (1) NO984124L (hu)
NZ (1) NZ331088A (hu)
PL (1) PL328810A1 (hu)
RO (1) RO118210B1 (hu)
UA (1) UA47465C2 (hu)
WO (1) WO1997032994A1 (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6210917B1 (en) * 1993-12-29 2001-04-03 The Regents Of The University Of California Method for suppressing multiple drug resistance in cancer cells
US6214571B1 (en) * 1993-12-29 2001-04-10 The Regents Of The University Of California Method for inhibiting adenylosuccinate synthetase activity in malignant methylthioadenosine phosphorylase deficient cells
US6911309B2 (en) * 1993-12-29 2005-06-28 The Regents Of The University Of Californnia Nucleic acids encoding MTAse
AU2001297765A1 (en) * 2000-12-05 2002-10-21 Incyte Genomics, Inc. Ligases
US20040043959A1 (en) * 2002-03-04 2004-03-04 Bloom Laura A. Combination therapies for treating methylthioadenosine phosphorylase deficient cells
AU2003261354A1 (en) * 2002-08-02 2004-02-23 The Regents Of The University Of California New uses for inhibitors of inosine monophosphate dehydrogenase
EP1594900A2 (en) * 2003-02-14 2005-11-16 Salmedix, Inc. Compositions and methods for the detection and treatment of methylthioadenosine phosphorylase deficient cancers
WO2006023010A1 (en) * 2004-08-18 2006-03-02 Salmedix, Inc. Alanosine formulations and methods of use
US20090030005A1 (en) * 2007-07-19 2009-01-29 Amgen Inc. Combinations for the treatment of cancer
BR112019011365A2 (pt) * 2016-12-01 2019-10-22 Glaxosmithkline Ip Dev Ltd métodos para tratar câncer
EP3727420A4 (en) * 2017-12-21 2022-04-06 Board of Regents, The University of Texas System ENZYME-MEDIATED DEPLETION OF ADENOSIN AND/OR METHYLTHIOADENOSIN
CN110124038A (zh) * 2019-05-08 2019-08-16 山东大学齐鲁医院 腺苷酸琥珀酸合成酶基因和/或其编码的蛋白的新应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4792520A (en) * 1984-02-16 1988-12-20 University Of Cincinnati Methods and kits for identifying mutagenic agents and molecular mutations in DNA in mammalian cells
US4822736A (en) * 1984-07-05 1989-04-18 Baylor College Of Medicine Amplification of adenosine deaminase genes in mammalian cells using adenosine, alanosine, uridine, and deoxycoformycin
US5118601A (en) * 1986-03-27 1992-06-02 The Regents Of The University Of California Method of screening purine nucleoside compounds or analogs for the ability to enhance the cellular synthesis and release of adenosine
US5030623A (en) * 1986-03-27 1991-07-09 The Regents Of The University Of California Methods for increasing extracellular adenosine and for stabilizing mast cells
CN1103820C (zh) * 1993-12-29 2003-03-26 加利福尼亚大学董事会 检测5'－甲硫腺苷磷酸化酶缺陷型哺乳动物细胞的方法

Also Published As

Publication number Publication date
KR19990087627A (ko) 1999-12-27
HUP9901858A3 (en) 1999-12-28
CZ286698A3 (cs) 1999-03-17
WO1997032994A1 (en) 1997-09-12
AU1838897A (en) 1997-09-22
AU722813B2 (en) 2000-08-10
JP2000509247A (ja) 2000-07-25
PL328810A1 (en) 1999-02-15
IL126114A0 (en) 1999-05-09
NO984124D0 (no) 1998-09-07
EP0902839A1 (en) 1999-03-24
ATE357223T1 (de) 2007-04-15
DE69737499D1 (de) 2007-05-03
EP0902839A4 (en) 2004-06-30
CA2244733A1 (en) 1997-09-12
UA47465C2 (uk) 2002-07-15
NZ331088A (en) 2000-08-25
EP0902839B1 (en) 2007-03-21
RO118210B1 (ro) 2003-03-28
BR9708002A (pt) 1999-07-27
NO984124L (no) 1998-09-07
CN1213406A (zh) 1999-04-07
EA199800806A1 (ru) 1999-02-25
EA001988B1 (ru) 2001-10-22
US5840505A (en) 1998-11-24

Similar Documents

Publication Publication Date Title
HUP9901858A2 (hu) Eljárás adenilszukcinát-szintetáz aktivitásának gátlására metil-tio-adenozin-foszforilázban hiányos sejtekben
AP1411A (en) Pyrrolo[2,3d] pyrimidine compositions and their use.
AP9701165A0 (en) C-4' adnosine kinase inhibitors.
ATE226205T1 (de) Verbindungen
AU8695901A (en) Methods for synthesizing nucleosides, nucleoside derivatives and non-nucleoside derivatives
AU4048989A (en) Alkoxy-4(1h)-pyridone derivatives, processes for preparing them and their use as drugs
HUT59151A (en) Process for producing purinylphosphonic acid derivatives and pharmaceutical compositions comprising same as active ingredient
YU81100A (sh) Derivati 2-(purin-9-il)tetrahidrofuran-3,4 diola
AP2000002013A0 (en) 2-(Purin-9-yl) -tetrahydrofuran-3, 4-diol derivatives.
MY119181A (en) Aryl pyrimidine derivatives
AP2000001947A0 (en) Novel crystalline forms of an antiviral benzidazole compound.
NO20020931L (no) Pyrrolo[2,3-d]pyrimidin-nukleosid-analoger
CY2462B1 (en) Cyclohexyl dihydrobenzofuranes.
MXPA04010307A (es) Derivados 5-oxo y 5-tio de 5h-indeno`1,2-bipiridina con enlace al receptor a2a de la adenosina y actividad inhibidora de la fosfodiesterasa para el tratamiento de trastornos neurodegenerativos y enfermedades relacionadas con la inflamacion.
GR3030733T3 (en) Sulphamate derivatives of 1,3,5(10)-estratriene derivatives, methods of producing them and pharmaceutical compounds containing them
NZ330944A (en) Peptide derivatives
HUP0300219A2 (hu) L-nukleozidokat, L-nukleotidokat és analógjaikat tartalmazó készítmények és alkalmazásuk
WO1999055843A3 (en) Efficient ex vivo expansion of cd4+ and cd8+ t-cells from hiv infected subjects
EP0715519A4 (en) IMMUNOMODULATIVE, ANTI-INFLAMMATORY AND ANTIPROLIFERATIVE COMPOUNDS: 5,6-DIDEOXY, 5-AMINO DERIVATIVES OF IDOSE AND 6-DEOXY, 6-AMINO DERIVATIVES OF GLUCOSE
EP0387757A3 (en) Use of 5'-deoxy-5'methylthioadenosine, s-adenosylmethionine and their salts in the preparation of pharmaceutical compositions favouring hair growth in subjects suffering from baldness, and relative pharmaceutical compositions
Matsuda et al. Nucleosides and nucleotides. 152. 1-(3-C-Ethynyl-β-D-ribo-pentofuranosyl) uracil as a broad spectrum antitumor nucleoside
EP0335770A3 (en) Novel fluorophosphonate nucleotide derivatives
Miura et al. The Antitumor Mechanism of 1‐(2‐Deoxy‐2‐fluoro‐4‐thio‐β‐D‐arabinofuranosyl)‐cytosine: Effects of Its Triphosphate on Mammalian DNA Polymerases
Hussain et al. Targeting tumor-associated immune suppression with selective protein kinase A type I (PKAI) inhibitors may enhance cancer immunotherapy
CA2320288A1 (en) Oligodeoxyribonucleotides comprising o6-benzylguanine and their use